Document is current
Any future updates will be listed below
-
Authors
Brzozowska, Natalia
Wu, Lily Y. D. https://orcid.org/0009-0000-1630-471X
Khodzhaeva, Vera
Griffiths, William J.
Duckworth, Adam
Jung, Hyunchul
Coorens, Tim H. H. https://orcid.org/0000-0002-5826-3554
Hooks, Yvette
Chambers, Joseph E. https://orcid.org/0000-0003-4675-0053
Campbell, Peter J. https://orcid.org/0000-0002-3921-0510
Marciniak, Stefan J. https://orcid.org/0000-0001-8472-7183
Hoare, Matthew https://orcid.org/0000-0001-5990-9604
-
Funding
Funding for this research was provided by:
Cancer Research UK (DRCPFA-Jun22\100001)
RCUK | Medical Research Council (MR/X00970X/1, MR/V028669/1, MR/V028669/1, MR/Y011813/1)
Alpha1 Foundation
Core grant from Wellcome Trust to the Wellcome Sanger Institute
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 11 February 2025
First Online: 10 March 2025
Competing interests
: P.J.C. is a co-founder, shareholder, consultant and, since acceptance of this report, employee of Quotient Therapeutics. M.H. is a consultant for Quotient Therapeutics, AstraZeneca and Boston Scientific and has received unrestricted scientific grants from Pfizer. The other authors declare no competing interests.
